Toxicity Profiles of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

IMPORTANCE: The recent development of targeted therapy and immunotherapy has made neoadjuvant therapy an attractive option for patients with hepatocellular carcinoma (HCC). However, surgeons are concerned that adverse effects of neoadjuvant therapy with these agents could lead to delayed or even can...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffiths, Christopher D., Zhang, Betty, Tywonek, Kasia, Meyers, Brandon M., Serrano, Pablo E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295000/
https://www.ncbi.nlm.nih.gov/pubmed/35849393
http://dx.doi.org/10.1001/jamanetworkopen.2022.22721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295000/
https://www.ncbi.nlm.nih.gov/pubmed/35849393
http://dx.doi.org/10.1001/jamanetworkopen.2022.22721

Ejemplares similares